FDA roadmap for predictive toxicology

U.S. FDA publishes roadmap to further develop predictive toxicology methods for risk assessment; public workshop to be held

Regulatory status of non-animal approaches

U.S. NAS workshop suggests comparing non-animal tests to human, not rodent, data, predicts alternatives to soon replace whole-animal tests; ECHA sees “long-way” until regulatory acceptance of alternatives for complex endpoints